IP Library Granted Patent US 11,382,539
Granted Patent B2
US 11,382,539 · App. 16/599,535 · Granted Jul 12, 2022

Analyte sensor

Inventors: Mark Brister (Encinitas, CA); Sean Saint (San Diego, CA); Vance Swanson (San Diego, CA); Nelson Quintana (San Diego, CA)
Assignee: DexCom, Inc.
A61B5/14532A61B5/1473A61B5/1495A61B5/14546A61B5/14865A61B5/412A61B5/6848A61B5/6849A61M5/1723A61B5/14542A61B2560/0223A61M5/14A61M5/16804A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,382,539
App. No.
16/599,535
Granted
Jul 12, 2022
Kind
B2
Abstract

Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into a host's peripheral vein or artery.

Claims (25)

1. A system for measuring glucose in a host and delivering medication to the host, the system comprising:

a catheter configured for insertion into a host and configured to deliver medication to the host, wherein the catheter comprises an exterior surface;

a continuous glucose sensor disposed at least partially on the exterior surface of the catheter and including a reference electrode coiled about the catheter and a working electrode, wherein the continuous glucose sensor is configured to generate sensor data indicative of glucose concentration; and

sensor electronics operatively connected to the continuous glucose sensor, wherein the sensor electronics are configured to determine a glucose concentration.

2. The system of claim 1 , wherein the continuous glucose sensor is integrally formed on the exterior surface of the catheter.

3. The system of claim 1 , wherein the continuous glucose sensor is electroplated onto the exterior surface of the catheter.

4. The system of claim 1 , wherein the continuous glucose sensor comprises a membrane system covering at least a portion of the working electrode.

5. The system of claim 1 , wherein the working electrode comprises an exposed electroactive surface.

6. The system of claim 1 , wherein the catheter is configured to be operatively connected to an infusion pump.

7. The system of claim 6 , wherein in response to sensor data received from the continuous glucose sensor, the sensor electronics are configured to communicate a therapy recommendation to the infusion pump, wherein the therapy recommendation comprises information relating to insulin amount.

8. The system of claim 1 , wherein the continuous glucose sensor is configured to be used subcutaneously.

9. The system of claim 1 , wherein the sensor electronics are configured to substantially continuously determine the glucose concentration.

10. The system of claim 1 , wherein the catheter includes a fluid connector, and the reference electrode is coiled about the catheter adjacent to or within the fluid connector.

11. The system of claim 10 , wherein the reference electrode is positioned to be in contact with fluid flowing through the fluid connector.

12. The system of claim 10 , wherein the reference electrode is located remote from the working electrode.

13. The system of claim 12 , wherein the reference electrode is positioned to not be inserted into the host with the catheter.

14. The system of claim 1 , wherein the catheter is perforated, and at least a portion of the working electrode or the reference electrode is disposed within a lumen of the catheter.

15. The system of claim 1 , wherein the working electrode comprises a first working electrode configured to measure a first signal comprising glucose and baseline, and further comprising a second working electrode configured to measure a second signal comprising baseline and not glucose.

16. The system of claim 15 , wherein the sensor electronics are configured to produce a glucose signal based on the first signal and the second signal.

17. The system of claim 15 , wherein the sensor electronics are configured to subtract the second signal from the first signal to obtain a glucose-only signal.

18. The system of claim 1 , wherein the sensor electronics are configured to:

measure a current signal indicating the glucose concentration; and

continuously integrate the measured current signal.

19. The system of claim 1 , wherein the sensor electronics are configured to average a plurality of reference data points to calibrate the continuous glucose sensor.

20. The system of claim 19 , wherein the sensor electronics are configured to match an average of the plurality of reference data points with a plurality of sensor data points to form a matched data pair.

Continuity (3)
Continuation 14256716 · Apr 18, 2014
Continuation 11543490 · Oct 4, 2006
Related Publication 20200046272A1 · Feb 13, 2020